These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18917553)

  • 21. Familial ovarian cancer: report of ovarian carcinoma in three sisters.
    Kariwiga G; Amoa AB; Mola G; Heywood S
    P N G Med J; 1997; 40(3-4):146-9. PubMed ID: 10750411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role and place of the prophilactic oophorectomy].
    Zlatkov V; Kostova P
    Akush Ginekol (Sofiia); 2004; 43 Suppl 4():43-8. PubMed ID: 15673014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical management for prophylactic oophorectomy in women with an inherited risk of ovarian cancer.
    Morice P; Pautier P; Delaloge S; Camatte S; Spatz A; Chompret A; Lhommé C; Duvillard P; Castaigne D
    Tumori; 2001; 87(4):S16-7. PubMed ID: 11693811
    [No Abstract]   [Full Text] [Related]  

  • 24. Laparoscopic prophylactic oophorectomy plus N3 lymphadenectomy for advanced rectosigmoid cancer.
    Liang JT; Lai HS; Wu CT; Huang KC; Lee PH; Shun CT
    Ann Surg Oncol; 2007 Jul; 14(7):1991-9. PubMed ID: 17447107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oophorectomy in ovarian tumor prophylaxis.
    LIU BL
    Chin Med J; 1960 Feb; 80():151-3. PubMed ID: 14417596
    [No Abstract]   [Full Text] [Related]  

  • 26. Cancer antigen 125 level after a bilateral salpingo-oophorectomy: what is the contribution of the ovary to the cancer antigen 125 level?
    van Altena AM; Holtsema H; Hendriks JC; Massuger LF; de Hullu JA
    Menopause; 2011 Feb; 18(2):133-7. PubMed ID: 20861755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
    Finch A; Beiner M; Lubinski J; Lynch HT; Moller P; Rosen B; Murphy J; Ghadirian P; Friedman E; Foulkes WD; Kim-Sing C; Wagner T; Tung N; Couch F; Stoppa-Lyonnet D; Ainsworth P; Daly M; Pasini B; Gershoni-Baruch R; Eng C; Olopade OI; McLennan J; Karlan B; Weitzel J; Sun P; Narod SA;
    JAMA; 2006 Jul; 296(2):185-92. PubMed ID: 16835424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen replacement therapy following oophorectomy in women with a family history of ovarian cancer.
    Eltabbakh GH; Piver MS; Hempling RE; Recio FO; Aiduk C
    Gynecol Oncol; 1997 Jul; 66(1):103-7. PubMed ID: 9234929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian Small Cell Carcinoma Hypercalcemic Type: A Case Report >.
    Rahma MB; Abbas M
    Ir Med J; 2016 Sep; 109(8):456. PubMed ID: 28124855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Familial history of ovarian carcinoma: policy].
    de Hullu JA; Kets CM; Massuger LF; Ligtenberg ML; van Ham MA; Hoogerbrugge N
    Ned Tijdschr Geneeskd; 2011; 155():A2392. PubMed ID: 21262027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignancies following bilateral salpingo-oophorectomy (BSO).
    Gotlieb WH; Barchana M; Ben-Baruch G; Friedman E
    Eur J Surg Oncol; 2006 Dec; 32(10):1231-4. PubMed ID: 16626923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Small cell carcinoma of the ovary].
    Bahri M; Lahmar R; Ben Salah H; Kallel N; Ben Amar M; Daoud J
    Cancer Radiother; 2014 Jun; 18(3):198-200. PubMed ID: 24637019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subsequent Oophorectomy and Ovarian Cancer after Hysterectomy for Benign Gynecologic Conditions at Chiang Mai University Hospital.
    Jitkunnatumkul A; Tantipalakorn C; Charoenkwan K; Srisomboon J
    Asian Pac J Cancer Prev; 2016; 17(8):3845-8. PubMed ID: 27644627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
    Rebbeck TR; Lynch HT; Neuhausen SL; Narod SA; Van't Veer L; Garber JE; Evans G; Isaacs C; Daly MB; Matloff E; Olopade OI; Weber BL;
    N Engl J Med; 2002 May; 346(21):1616-22. PubMed ID: 12023993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ovarian conservation versus bilateral oophorectomy at the time of hysterectomy for benign disease.
    Parker WH
    Menopause; 2014 Feb; 21(2):192-4. PubMed ID: 23880797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ovarian metastases in colorectal cancer.
    Omranipour R; Abasahl A
    Int J Gynecol Cancer; 2009 Dec; 19(9):1524-8. PubMed ID: 19955930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of ovarian cancer: a survey of the practice of prophylactic oophorectomy by consultant gynaecologists in Ireland.
    Geary M; Geoghegan A; Foley M
    Ir Med J; 1997; 90(5):186-7. PubMed ID: 9345830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic oophorectomy.
    Jacobs I; Oram D
    Br J Hosp Med; 1987 Nov; 38(5):440-4, 448-9. PubMed ID: 3318981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer.
    Meeuwissen PA; Seynaeve C; Brekelmans CT; Meijers-Heijboer HJ; Klijn JG; Burger CW
    Gynecol Oncol; 2005 May; 97(2):476-82. PubMed ID: 15863147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.